Skip to content

Nasdaq · CIK 0001802768

RPRX Royalty Pharma plc

Insider trading from SEC Form 4. Last filing 7 d ago. Close $56.93 on Oct 9, 2026, +64% from the 52-week low and -11% from the high.

Last 90 days

Net insider value
-$6.3M
more sold than bought
Buys
0
$0 by 0 insiders
Sells
3
$6.3M by 2 insiders
Insiders on file
13
with a Form 4 at this company

Price and insider trades, last year

RPRXOct 9, 2026 · close 56.93

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

Open-market buys and sells at Royalty Pharma plc, scored.

ScoreInsiderValueHoldingsPrice contextFiled
36WeakMarshall Urist
EVP, Research & Investments
sell
$236k
4,126 shares
-100%+63% from low-11% from high
36WeakMarshall Urist
EVP, Research & Investments
sell
$239k
4,126 shares
-50%+69% from low-9% from high
43ModerateChristopher Hite
EVP & Chairman, Partnering
sell
$5.9M
100,000 shares
-27%+71% from low-9% from high

Transactions

The last 36 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Oct 5, 2026Marshall Urist
EVP, Research & Investments
SOpen-market sale
Class A Ordinary Shares10b5-1
-4,126$57.10$236k07 d ago
Sep 30, 2026Bonnie L Bassler
director
AGrant or award
Class A Ordinary Shares
+642$58.41$37k79,82312 d ago
Sep 28, 2026Marshall Urist
EVP, Research & Investments
SOpen-market sale
Class A Ordinary Shares10b5-1
-4,126$57.88$239k4,12612 d ago
Sep 22, 2026Christopher Hite
EVP & Chairman, Partnering
SOpen-market sale
Class A Ordinary Sharesindirect: By SCH Investment Partners LLC10b5-1
-96,073$58.51$5.6M274,32818 d ago
Sep 22, 2026Christopher Hite
EVP & Chairman, Partnering
SOpen-market sale
Class A Ordinary Sharesindirect: By SCH Investment Partners LLC10b5-1
-3,927$58.93$231k270,40118 d ago
Jun 30, 2025Bonnie L Bassler
director
AGrant or award
Class A Ordinary Shares
+1,064$35.24$37k71,118Jun 30, 2025
Jun 30, 2025Henry A Fernandez
director
AGrant or award
Class A Ordinary Shares
+1,064$35.24$37k65,324Jun 30, 2025
May 16, 2025Terrance P. Coyne
EVP & CFO
AGrant or award
Class E Ordinary Sharesderivativeindirect: See Footnote (1)(2)
+1,807,277$0.00$01,807,277May 20, 2025
May 16, 2025Christopher Hite
EVP & Vice Chairman
AGrant or award
Class E Ordinary Sharesderivativeindirect: See Footnote (1)(2)
+1,238,789$0.00$01,238,789May 20, 2025
May 16, 2025Pablo G. Legorreta
CEO, Chairman of the Board
JOther
Class A Ordinary Shares
+530,348$0.00$0882,495May 20, 2025
May 16, 2025Marshall Urist
EVP, Research & Investments
AGrant or award
Class E Ordinary Sharesderivativeindirect: See Footnote (1)(2)
+1,356,528$0.00$01,356,528May 20, 2025
May 16, 2025George W. Lloyd
EVP, Investments & CLO
AGrant or award
Class E Ordinary Sharesderivativeindirect: See Footnote (1)(2)
+1,944,471$0.00$01,944,471May 20, 2025
May 16, 2025Pablo G. Legorreta
CEO, Chairman of the Board
AGrant or award
Class E Ordinary Sharesderivativeindirect: By PL RPH Holdings, LLC
+13,356,742$0.00$013,356,742May 20, 2025
May 16, 2025Pablo G. Legorreta
CEO, Chairman of the Board
JOther
Option (Right to Buy)derivativeindirect: By PL RPH Holdings, LLC
+857,138$0.00$0857,138May 20, 2025
May 13, 2025Catherine M. Engelbert
director
AGrant or award
Class A Ordinary Shares
+7,614$0.00$051,128May 15, 2025
May 12, 2025Pablo G. Legorreta
CEO, Chairman of the Board
GGift
Class B Ordinary Sharesderivativeindirect: By Spouse
-867,180$0.00$00May 14, 2025
May 13, 2025Gregory Norden
director
AGrant or award
Class A Ordinary Shares
+7,614$0.00$083,688May 14, 2025
May 13, 2025Ted W Love
director
AGrant or award
Class A Ordinary Shares
+7,614$0.00$053,848May 14, 2025
May 13, 2025Henry A Fernandez
director
AGrant or award
Class A Ordinary Shares
+7,614$0.00$064,260May 14, 2025
May 13, 2025Errol B Desouza
director
AGrant or award
Class A Ordinary Shares
+7,614$0.00$081,352May 14, 2025
May 13, 2025Vlad Coric
director
AGrant or award
Class A Ordinary Shares
+7,614$0.00$010,798May 14, 2025
May 13, 2025Bonnie L Bassler
director
AGrant or award
Class A Ordinary Shares
+7,614$0.00$070,054May 14, 2025
May 13, 2025David C Hodgson
director
AGrant or award
Class A Ordinary Shares
+7,614$0.00$033,328May 14, 2025
May 12, 2025Pablo G. Legorreta
CEO, Chairman of the Board
GGift
Class B Ordinary Sharesderivative
+867,180$0.00$00May 14, 2025
May 8, 2025George W. Lloyd
EVP, Investments & CLO
AGrant or award
Class A Ordinary Sharesindirect: By GWL 2023 G HoldCo LLC
+48,646$0.00$048,646May 9, 2025
May 8, 2025Marshall Urist
EVP, Research & Investments
AGrant or award
Class A Ordinary Shares
+36,484$0.00$083,151May 9, 2025
May 8, 2025Pablo G. Legorreta
CEO, Chairman of the Board
AGrant or award
Class A Ordinary Shares
+288,352$0.00$0352,147May 9, 2025
May 8, 2025Christopher Hite
EVP & Vice Chairman
AGrant or award
Class A Ordinary Sharesindirect: By SCH Investment Partners LLC
+48,646$0.00$0648,646May 9, 2025
May 8, 2025Terrance P. Coyne
EVP & CFO
AGrant or award
Class A Ordinary Sharesindirect: TPC RP EPA1 LLC
+48,646$0.00$048,646May 9, 2025
Apr 21, 2025Vlad Coric
director
AGrant or award
Class A Ordinary Shares
+3,184$0.00$03,184Apr 21, 2025
Mar 31, 2025Bonnie L Bassler
director
AGrant or award
Class A Ordinary Shares
+1,141$32.87$37k62,440Apr 1, 2025
Mar 31, 2025Henry A Fernandez
director
AGrant or award
Class A Ordinary Shares
+1,141$32.87$37k56,646Apr 1, 2025
Feb 14, 2025Christopher Hite
EVP & Vice Chairman
CConversion
Class A Ordinary Sharesindirect: By SCH Investment Partners LLC
+300,000$0.00$0600,000Feb 18, 2025
Feb 14, 2025Christopher Hite
EVP & Vice Chairman
CConversion
LP interests in RPI US Partners 2019, LPderivativeindirect: By SCH Investment Partners LLC
-30,000$0.00$086,641Feb 18, 2025
Dec 31, 2024Bonnie L Bassler
director
AGrant or award
Class A Ordinary Shares
+1,503$24.94$37k61,299Jan 2, 2025
Dec 31, 2024Henry A Fernandez
director
AGrant or award
Class A Ordinary Shares
+1,503$24.94$37k55,505Jan 2, 2025

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

RPRX insider trading: Royalty Pharma plc | InsiderTell